895
Participants
Start Date
October 31, 2018
Primary Completion Date
July 30, 2021
Study Completion Date
April 27, 2026
olaparib
300 mg (2 x 150 milligrams (mg) tablets) twice daily
abiraterone acetate
1000 milligrams (mg) once daily
Research Site, Darlinghurst
Research Site, Waratah
Research Site, Kingswood
Research Site, St Albans
Research Site, Box Hill
Research Site, Herston
Research Site, Greenslopes
Research Site, Kurralta Park
Research Site, Ghent
Research Site, Orbassano
Research Site, Goyang-si
Research Site, New Hyde Park
Research Site, Brooklyn
Research Site, Syracuse
Research Site, Caen
Research Site, Rochester
Research Site, Girona
Research Site, Philadelphia
Research Site, Milan
Research Site, Milan
Research Site, Besançon
Research Site, Pavia
Research Site, Durham
Research Site, Madrid
Research Site, Bremen
Research Site, Málaga
Research Site, Quimper
Research Site, Charleston
Research Site, Myrtle Beach
Research Site, Istanbul
Research Site, Birmingham
Research Site, Izmir
Research Site, Karşıyaka
Research Site, Mettmann
Research Site, Seville
Research Site, Daegu
Research Site, Jeffersonville
Research Site, Duisburg
Research Site, Detroit
Research Site, Angers
Research Site, Grand Rapids
Research Site, Cologne
Research Site, Bergisch Gladbach
Research Site, Heinsberg
Research Site, Milwaukee
Research Site, Vandœuvre-lès-Nancy
Research Site, Bozeman
Research Site, Lisle
Research Site, St Louis
Research Site, Omaha
Research Site, Pierre-Bénite
Research Site, New Orleans
Research Site, Nürtingen
Research Site, Freiburg im Breisgau
Research Site, Napoli
Research Site, Denver
Research Site, Tucson
Research Site, Tucson
Research Site, Ulm
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Nuremberg
Research Site, San Diego
Research Site, Šaľa
Research Site, Clovis
Research Site, Sacramento
Research Site, Anchorage
Research Site, Viña del Mar
Research Site, Temuco
Research Site, Santiago
Research Site, Santiago
Research Site, Paramus
Research Site, Belo Horizonte
Research Site, Curitiba
Research Site, Fortaleza
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, Calgary
Research Site, Edmonton
Research Site, Kelowna
Research Site, Halifax
Research Site, London
Research Site, Toronto
Research Site, Toronto
Research Site, Greenfield Park
Research Site, Montreal
Research Site, Montreal
Research Site, Brno
Research Site, Prague
Research Site, Prague
Research Site, Prague
Research Site, Bunkyō City
Research Site, Hirakata-shi
Research Site, Kanazawa
Research Site, Kashihara-shi
Research Site, Kawagoe-shi
Research Site, Kita-gun
Research Site, Kyoto
Research Site, Maebashi
Research Site, Miyazaki
Research Site, Nagoya
Research Site, Osaka
Research Site, Osaka
Research Site, Osakasayama-shi
Research Site, Sagamihara-shi
Research Site, Sakura-shi
Research Site, Shinjuku-ku
Research Site, Toon-shi
Research Site, Yokohama
Research Site, Hilversum
Research Site, Nijmegen
Research Site, Tilburg
Research Site, Bratislava
Research Site, Prešov
Research Site, Trenčín
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Madrid
Research Site, Adana
Research Site, Ankara
Research Site, Ankara
Research Site, Guildford
Research Site, Manchester
Research Site, Sheffield
Research Site, Southampton
Research Site, Swansea
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
AstraZeneca
INDUSTRY